
Name | Lemara |
Description |
Lemara tablets contain an active substance called letrozole. It belongs to a group of medicines called aromatase inhibitors. It is a hormonal (or “endocrine”) breast cancer treatment. Growth of breast cancer is frequently stimulated by oestrogens which are female sex hormones. Lemara reduces the amount of oestrogen by blocking an enzyme (“aromatase”) involved in the production of oestrogens and therefore may block the growth of breast cancer that needs oestrogens to grow. As a consequence, tumour cells slow or stop growing and/or spreading to other parts of the body. |
Active Ingredient | Letrozole |
Indication |
|
Strengths | 2.5 mg |
Business Partner | MYLAN SAS |
Origin | FRANCE |